{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:37:52Z","timestamp":1792291072255,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1994,12,1]],"date-time":"1994-12-01T00:00:00Z","timestamp":786240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[1994,12]]},"DOI":"10.1007\/bf03165027","type":"journal-article","created":{"date-parts":[[2009,9,26]],"date-time":"2009-09-26T10:27:44Z","timestamp":1253960864000},"page":"245-251","source":"Crossref","is-referenced-by-count":41,"title":["Assessment of dopamine metabolism in brain of patients with dementia by means of18F-fluorodopa and PET"],"prefix":"10.1007","volume":"8","author":[{"given":"Masatoshi","family":"Itoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Meguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hatazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetada","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03165027_CR1","first-page":"174","volume-title":"Psychopharmacology of the limbic system","author":"B Scatton","year":"1984","unstructured":"Scatton B, Zivkovic B. Neuroleptics and the limbic system.In Psychopharmacology of the limbic system. Trimble MR & Zarifian E (eds.), Oxford, Oxford University Press, pp. 174\u2013197, 1984."},{"key":"BF03165027_CR2","first-page":"599","volume-title":"The mesolimbic dopamine system: from motivation to action","author":"JD Salamone","year":"1991","unstructured":"Salamone JD. Behavioral pharmacology of dopamine system: a new synthesis.In The mesolimbic dopamine system: from motivation to action. Willner P, Scheel Krueger J (eds.), Chichester, John Wiley & Sons, pp. 599\u2013614, 1991."},{"key":"BF03165027_CR3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.35.4.453","volume":"35","author":"R Mayeux","year":"1985","unstructured":"Mayeux R, Stem Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups.Neurology 35: 453\u2013461, 1985.","journal-title":"Neurology"},{"key":"BF03165027_CR4","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/WNL.35.11.1544","volume":"35","author":"HC Chui","year":"1985","unstructured":"Chui HC, Teng EL, Henderson V, Moy AC. Clinical subtypes of dementia of the Alzheimer type.Neurology 35: 1544\u20131550, 1985.","journal-title":"Neurology"},{"key":"BF03165027_CR5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0022-510X(85)90135-2","volume":"69","author":"C Nahmias","year":"1985","unstructured":"Nahmias C, Garnett ES, Firnau G, Lang A. Striatal dopamine distribution in Parkinsonian patients during life.J Neurolog Sci 69: 223\u2013320, 1985.","journal-title":"J Neurolog Sci"},{"key":"BF03165027_CR6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/jnnp.49.8.853","volume":"49","author":"KL Leenders","year":"1986","unstructured":"Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES, et al. Brain dopamine metabolism in patients with Parkinson\u2019s disease measured with positron emission tomography.J Neurol Neurosurg Psychiat 49: 853\u2013860, 1986.","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"BF03165027_CR7","first-page":"P125","volume":"26","author":"MJ Adam","year":"1985","unstructured":"Adam MJ, Abeysekera B, Ruth TJ, Grierson JR, Pate BD. Synthesis of 6-(F-18)L-fluoro-dopausing F-18 labeled acetyl hypofluorite.J Nucl Med 26: P125, 1985.","journal-title":"J Nucl Med"},{"key":"BF03165027_CR8","unstructured":"Watanuki S, Ishii K, Orihara H, Fukuda H, Matsuzawa T. Status of multi-ring high-resolution positron emission tomography system PT931. CYRIC Annual Report 1986: 250\u2013244, 1986."},{"key":"BF03165027_CR9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","volume":"5","author":"CS Patlak","year":"1985","unstructured":"Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations.J Cereb Blood Flow Metabol 5: 584\u2013590, 1985.","journal-title":"J Cereb Blood Flow Metabol"},{"key":"BF03165027_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","volume":"3","author":"CS Patlak","year":"1983","unstructured":"Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.J Cereb Blood Flow Metabol 3: 1\u20137, 1983.","journal-title":"J Cereb Blood Flow Metabol"},{"key":"BF03165027_CR11","first-page":"103","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987","unstructured":"American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. DSM-III-R. Washington DC, Amer Psychiat Ass, pp. 103\u2013122, 1987."},{"key":"BF03165027_CR12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","volume":"32","author":"VC Hachinski","year":"1975","unstructured":"Hachinski VC, Iliff LD, Zilka E, DuBoulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia.Arch Neurol 32: 632\u2013637, 1975.","journal-title":"Arch Neurol"},{"key":"BF03165027_CR13","first-page":"1","volume-title":"Handbook on Statistics on PC","author":"Y Tanaka","year":"1986","unstructured":"Tanaka Y, Tarumizu T.Handbook on Statistics on PC, III. Tokyo, Kyoritsu Shuppan Inc., pp. 1\u201315, 1986."},{"key":"BF03165027_CR14","first-page":"363","volume":"29","author":"G Firnau","year":"1988","unstructured":"Firnau G, Sood S, Chirakal R, Nahmias C, Garnett ES. Metabolites of 6-[18F]fluoro-L-dopa in the human blood. JNucl Med 29: 363\u2013369, 1988.","journal-title":"J Nucl Med"},{"key":"BF03165027_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0024-3205(90)90228-J","volume":"47","author":"WP Melega","year":"1990","unstructured":"Melega WP, Hoffman JM, Luxen A, Nissenson CHK, Phelps ME, Barrio JR. The effects of carbidopa on the metabolism of 6-[F-18]fluoro-L-dopa in rats, monkeys and humans.Life Sci 47: 149\u2013157, 1990.","journal-title":"Life Sci"},{"key":"BF03165027_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/jcbfm.1993.8","volume":"13","author":"H Hoshi","year":"1993","unstructured":"Hoshi H, Kuwabara H, Leger G, Cumming P, Guttman M, Gjedde A. 6-[18F]fiuoro-L-DOPA metabolism in living human brain: A comparison of six analytical methods.J Cereb Blood Flow Metab 13: 57\u201369, 1993.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF03165027_CR17","first-page":"297","volume":"3","author":"SI Rapoport","year":"1991","unstructured":"Rapoport SI. Positron emission tomography in Alzheimer\u2019s disease in relation to disease pathogenesis: a critical review.Cerebrovasc Brain Metab Rev 3: 297\u2013335, 1991.","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"BF03165027_CR18","first-page":"122","volume":"5","author":"JS Meyer","year":"1993","unstructured":"Meyer JS, Terayama Y, Takashima S. Cerebral circulation in the elderly.Cerebrovasc Brain Metab Rev 5: 122\u2013146, 1993.","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"BF03165027_CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1991.tb00192.x","volume":"640","author":"WD Heiss","year":"1991","unstructured":"Heiss WD, Szelies B, Kessler J, Herholz K. Abnormalities of energy metabolism in Alzheimer\u2019s disease studied with PET.Ann NY Acad Sci 640: 65\u201371, 1991.","journal-title":"Ann NY Acad Sci"},{"key":"BF03165027_CR20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.STR.23.4.594","volume":"23","author":"Y Kuwabara","year":"1992","unstructured":"Kuwabara Y, Ichiya Y, Otsuka M, Masuda K, Ichimiya A, Fujishima M. Cerebrovascular responsiveness to hyper-capnia in Alzheimer\u2019s dementia and vascular dementia of the binswanger type.Stroke 23: 594\u2013598, 1992.","journal-title":"Stroke"},{"key":"BF03165027_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF01249444","volume":"38","author":"A Carlsson","year":"1976","unstructured":"Carlsson A, Winblad B. Influence of age and time interval between death and autopsy on dopamine and 3-methoxy-tyramine levels in human basal ganglia.J Neural Transm 38: 271\u2013276, 1976.","journal-title":"J Neural Transm"},{"key":"BF03165027_CR22","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.1990.00530120034007","volume":"47","author":"KL Leenders","year":"1990","unstructured":"Leenders KL, Salmon EP, Turton D, Tyrrell P, Perani D, Brooks DJ, et al. The nigro-striatal dopaminergic system assessedin vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson\u2019s disease.Arch Neurol 47: 1290\u20131298, 1990.","journal-title":"Arch Neurol"},{"key":"BF03165027_CR23","first-page":"S410","volume":"13","author":"S Takikawa","year":"1993","unstructured":"Takikawa S, Dahwan V, Chaly T, Robeson W, Spetsieris P, Eidelberg D. Does striatal FDOPA uptake decrease with age?J Cereb Blood Flow Metab 13: S410, 1993.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF03165027_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000213174","volume":"36","author":"M Itoh","year":"1990","unstructured":"Itoh M, Hatazawa J, Miyazawa H, Matsui H, Meguro K, Yanai K, et al. Stability of cerebral blood flow and oxygen metabolism during normal aging.Gerontology 36: 43\u201348, 1990.","journal-title":"Gerontology"},{"key":"BF03165027_CR25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneur.1990.00530120062011","volume":"47","author":"PJ Tyrrell","year":"1990","unstructured":"Tyrrell PJ, Sawle GV, Ibanez V, Bloomfield PM, Leenders KL, Frackowiak RSJ, et al. Clinical and positron emission tomographic studies in the \u2019extrapyramidal syndrome\u2019 of dementia of the Alzheimer type.Arch Neurol 47: 1318\u20131323, 1990.","journal-title":"Arch Neurol"},{"key":"BF03165027_CR26","first-page":"497","volume-title":"the mesolimbic dopamine system: From motivation to action","author":"TW Robins","year":"1991","unstructured":"Robins TW. Cognitive deficits in schizophrenia and Parkinson\u2019s disease: Neural basis and the role of dopamine.In the mesolimbic dopamine system: From motivation to action, Willner P, Sheel-Krueger (eds.), Chichester, Jon Wiley & Sons, pp. 497\u2013528, 1991."},{"key":"BF03165027_CR27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/jnr.490270415","volume":"27","author":"CG Gottfries","year":"1990","unstructured":"Gottfries CG. Neurochemical aspects on aging and diseases with cognitive impairment.J Neurosci Res 27: 541\u2013547, 1990.","journal-title":"J Neurosci Res"},{"key":"BF03165027_CR28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-0404.1989.tb03807.x","volume":"79","author":"A Wallin","year":"1989","unstructured":"Wallin A, Alafuzoff I, Carlsson A, Eckernaes SA, Gottfries CG, Karlsson I, et al. Neurotransmitter deficits in a nonmulti-infarct category of vascular dementia.Acta Neurol Scand 79: 397\u2013406, 1989.","journal-title":"Acta Neurol Scand"},{"key":"BF03165027_CR29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0022-510X(93)90216-L","volume":"115","author":"H Nagasawa","year":"1993","unstructured":"Nagasawa H, Saito H, Kogure K, Hatazawa J, Itoh M, Fujiwara T, et al. 6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography.J Neurolog Sci 115: 136\u2013143, 1993.","journal-title":"J Neurolog Sci"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03165027\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T02:52:09Z","timestamp":1558493529000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03165027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,12]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1994,12]]}},"alternative-id":["BF03165027"],"URL":"https:\/\/doi.org\/10.1007\/bf03165027","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,12]]}}}